2008
1
Akita H.,Doki Y., Yano M., Miyata H., Miyashiro I., Ohigashi H., Ishikawa O., Nishiyama A., Imaoka S. Effects of neoadjuvant chemotherapy on primary tumor and lymph node metastasis in esophageal squamous cell carcinoma: additive association with prognosis. Dis Esophagus 19 ,
2
Akita H.,Hikita H., Yamanouchi E., Marubashi S., Nagano H., Umeshita K., Dono K., Tsutsui S., Hayashi N., Monden M.
Use of a metallic-wall stent in the magnet compression anastomosis technique for bile duct obstruction after liver transplantation.
Liver Transpl. 14(1)：118-120,2008.1.
3
Akita H.,Sasaki Y., Yamada T., Gotoh K., Ohigashi H., Eguchi H., Yano M., Ishikawa O., Imaoka S.
Real-time intraoperative assessment of residual liver functional reserve using pulse dye densitometry.
World J Surg 32(12)：2668-2674,2008..
4
Atarashi K.,Nishimura J., Shima T., Umesaki Y., Yamamoto M., Onoue M., Yagita H., Ishii N., Evans R., Honda K., Takeda K.????
ATP drives lamina propria TH17 cell differentiation
Nature 455 808-812,2008..
5
Doki Y.,Okada K., Miyata H., Yamasaki M., Fujiwara Y., Takiguchi S., Yasuda T.,
Hirao T., Nagano H., Monden M.
Long-term and short-term evaluation of esophageal reconstruction using the colon or the jejunum in esophageal cancer patients after gastrectomy.
Dis Esophagus 21(2)：132-138,2008..
6
Eguchi S.,Kanematsu T., Arii S., Okazaki M., Okita K., Omata M., Ikai I., Kudo M., Kojiro M., Makuuchi M., Monden M., Matsuyama Y., Nakanuma Y., Takayasu K.
Comparison of the outcomes between an anatomical subsegmentectomy and a non-anatomical minor hepatectomy for single hepatocellular carcinomas based on a Japanese nationwide survey
Surgery 143(4)：469-475,2008.4.
7
Ezumi K.,Yamamoto H., Murata K., Higashiyama M., Damdinsuren B., Nakamura Y., Kyo N., Okami J., Ngan CY., Takemasa I., Ikeda M., Sekimoto M., Matsuura N., Nojima H., Monden M.
Aberrant Expression of Connexin 26 Is Associated with Lung Metastasis of Colorectal Cancer.
Clin Cancer Res.? 14(3)：677-684,2008.2.1
8
Ezumi K.,Yamamoto H., Takemasa I., Nomura M., Ikeda M., Sekimoto M., Nojima H., Monden M.
Dacarbazine-Doxorubicin Therapy Ameliorated an Extremely Aggressive Mesenteric Desmoid Tumor Associated with Familial Adenomatous Polyposis: Report of a Case
Jpn J Clin Oncol 38(3)：222-226,2008..
9
Fujiwara Y.,Doki Y., Taniguchi H., Sohma I., Takiguchi S., Miyata H., Yamasaki M., Monden M.
Genetic detection of free cancer cells in the peritoneal cavity of the patient with gastric cancer:present status and future perspectives.
Gastric Cancer? 10 197-204,2007..
10
Fujiwara Y.,Yong Zhang., Fujiwara Y., Doki Y., Takiguchi S., Yasuda T., Miyata H.,Yamasaki M., Chew Yee Ngan., Yamamoto H., Qingyong Ma., Monden M.
Overexpression of Tyrosine Kinase B Protein as a Predictor for Distant Metastases and Prognosis in Gastric Carcinoma
Oncology 75 17-26,2008..
11
Fukui S.,Kitagawa-Sakakida S., Kawamata S., Matsumiya G., Kawaguchi N., Matsuura N., Sawa Y.
Therapeutic effect of midkine on cardiac remodeling in infarcted rat hearts.
Ann Thorac Surg 85(2)：562-570,2008..
12
Fukuyoshi Y.,Fukuyoshi Y., Inoue H., Kita Y., Ishida T., Mori M.
EML4-ALK fusion transcript is not found in gastrointestinal and breast cancers
Br J Cancer 98 1536-1539,2008.4.
13
Fumimoto Y.,Tamagawa K., Ito T., Sawa Y., NIshida T.?
Localized Giant Inflammatory Polyposis of The Ileocecum Associated with Crohn’s Disease: Report of a Case
Case Reports in Gastroenterology 2 128-133,2008..
14
Fumimoto Y.,Tanemura M., Hoshida Y., Nishida T., Sawa Y., Ito T.????
Graft Duodenal Perforation due to Internal Hernia after Simultaneous Pancreas-Kidney Transplantation: Report of a Case
Case Reports in Gastroenterology 2 244-249,2008..
15
Haraguchi N,Ohkuma M., Sakashita H., Matsuzaki S., Tanaka F., Mimori K., Kamohara Y.,
Inoue H., Mori M.
CD133+CD44+ population efficiently enriches colon cancer initiating cells
Ann Surg Oncol 15(10)：2927-2933,2008..
16
Hasegawa K.,Makuuchi M., Takayama T., Kokud N., Arii S., Okazaki M., Okita K., Omata M., Kudo M., Kojiro M., Nakanuma Y., Takayasu K., Monden M., Matsuyama Y., Ikai I.
Surgical resection vs. percutaneous ablation for hepatocellular carcinoma: A preliminary report of the Japanese nationwide survey
Journal of Hepatology? 49(4)：589-594,2008..
17
Higuchi I,Yasuda T., Yano M., Doki Y., Miyata H., Tatsumi M., Fukunaga H., Takiguchi S., Fujiwara Y., Hatazawa J., Monden M.
Lack of fludeoxyglucose F 18 uptake in posttreatment positron emission tomography as a significant predictor of survival after subsequent surgery in multimodality treatment for patients with locally advanced esophageal squamous cell carcinoma.
J Thorac Cardiovasc Surg.? 136(1)：205-212,2008..
18
Hirokazu Uyama,Nagano H., Nakamura H., Murakami T., Nakamura H., Monden M., Hayashi N.
New chemotherapy for patients with advanced hepatocellular carcinoma: Pilot study of -interferon and doxorubicin one-shot intra-arterial chemotherapy
Hepatology Research 37(12)：1018-1025,2007..
19
Horino J.,Fujimoto M., Terabe F., Serada S., Takahashi T., Soma Y., Tanaka K., Chinen T., Yoshimura A., Nomura S., Kawase I., Hayashi N., Kishimoto T., Naka T.
Supressor of cytokine signaling-1 ameliorates dextran sulfate sodium-induced colitis in mice.
International Immunology. 20(6)：735-762,2008..
20
Horino J.,Fujimoto M., Terabe F., Serada S., Takahashi T., Souma Y., Tanaka K., Chinen T., Yoshimura A., Nomura S., Kawase I., Hayashi N., Kishimoto T., Naka T.?
Supressor of cytokine signaling-1 ameliorates dextran sulfate sodium-induced colitis in mice.
International Immunology 20 753-762,2008..
21
Iannaccone R.,Piacentini F., Murakami T., Paradis V., Belghiti J., Hori M., Kim T.,
Durand F., Wakasa K., Monden M., Nakamura H., Passariello R., Vilgrain V.
Hepatocellular carcinoma in patients with nonalcoholic fatty liver disease:helical CT and MR imaging findings with clinical-pathologic comparison.
Radiology. 243(2)：422-430,2007.5.
22
Ieta K.,Ieta K., Tanaka F., Haraguchi N., Kita Y., Sakashita H., Mimori K., Matsumoto T., Inoue H., Kuwano H., Mori M.
Biological and genetic characteristics of tumor - initiating cells in colon cancer
Ann Surg Oncol? 15(2)：638-648,2008.4.
23
Imai Y.,Murakami T., Hori M., Fukuda K., Kim T., Marukawa T., Abe H., Kuwabara M.,
Onishi H., Tsuda K., Sawai Y., Kurokawa M., Hayashi N., Monden M., Nakamura H.
Hypervascular hepatocellular carcinoma: Combined dynamic MDCT and SPIO-enhanced MRI versus combined CTHA and CTAP.
Hepatol Res. 38(2)：147-158,2008..
24
Inoue M.,Maeda J., Ohta M., Sawabata N., Matsuura N., Okumura M.
Detection of occult lymph node metastasis in lung cancer patients using molecular technique
Curr Res in Cancer 2 141-149,2008..
25
Ishida T.,Obata Y., Ohara N., Matsushita H., Sato S., Uenaka A., Saika T., Miyamura T., Chayama K, Nakamura Y., Wada H., Yamashita T., Morishima T., Lloyd J. Old ,Nakayama E.
Identification of the HERV-K gag antigen in prostate cancer by SEREX using autologous patient serum and its immunogenicity
Cancer Immunity 8 220-225,2008.11.13
26
Ishii H.,Iwatsuki M., Ieta K., Ohta D., Haraguchi N., Mimori K., Mori M.
Cancer stem cells and chemoradiation resistance.
Cancer Science 99(10)：1871-1877,2008..
27
Ishii H.,Mimori K., Ishikawa K., Okumura H., Pichiorri F., Druck T., Vecchione A., Saito T., Mori M., Huebner K.
Fhit-deficient hematopoietic stem survive hydroquinone exposure precancer ous changes.
Cancer Res 68(10)：3662-3670,2008.4.
28
Ishikawa K.,Kamohara Y., Tanaka F., Haraguchi N., Inoue H., Mori M.
Mitotic centromere-associated kinesin is a novel marker for prognosis and lymph node metastasis in colorectal cancer
Br J Cancer 98 1824-1829,2008..
29
Kamohara Y.,Haraguchi N., Mimori K., Tanaka F., Inoue H., Mori M., Kanematsu T.
The search for cancer stem cells in hepatocellular carcinoma
Oncologene119-124,2008..
30
Kato T.,Mishima H., Ikenaga M., Murata K., Ishida H., Fukunaga M., Ota H., Tominaga
S., Ohnishi T., Amano M., Ikeda K., Ikeda M., Sekimoto M., Sakamoto J., Monden M.
A phase II study of irinotecan in combination with doxifluridine, an intermediate
form of capecitabine, in patients with metastatic colorectal cancer.
31
Kawabata R.,Fujiwara Y., Doki Y., Fujita J., Tsukahara Y., Yamasaki M., Miyata H., Takiguchi S., Monden M.
Phase I/II study of a combination of S-1 and weekly paclitaxel in patients with advanced or recurrent gastric cancer.
Oncology. 72(3-4)：219-225,2008.1.7
32
Kawamoto K.,Tanemura? M., Ito T., Deguchi T., Machida T., Nishida T., Doki Y., Mori M., Sawa Y.?????
Prolonged survival of pig islets xenograft by adenovirus-mediated expression of either the membrane-bound human FasL or the human decoy Fas antigen gene
Xenotransplantation 15(5)：333-343,2008..
33
Kawamoto K.,Tanemura M., Deguchi T., Machida T., Nishida T., Sawa Y., Mori M., Doki Y., Ito T.
In vivo controlling of cellular response to pig islet xenografts by adenovirus-mediated expression of either membrane-bound human FasL or human decoy Fas
Am J Transplant. 8(2)：288-297,2008..
34
Kawamoto K.,Tanemura M., Saga A., Komoda H., Fumimoto Y., Deguchi T., Machida T., Sawa Y., Nishida T., Ito T.
Adenoviral-mediated overexpression of either membrane-bound human FasL or human decoy Fas can prolong pig islet xenograft survival in a rat transplant model.
Transplant Proc. 40(2)：477-479,2008..
35
Kim MS.,Chang X., Yamashita K., Naqpal JK., Baek JH., Wu G., Trink B., Ratovitski EA.,
Mori M., Sidransky D.
Aberrant promoter methylation and tumor suppressive activity of the DFNA5 gene in colorectal carcinoma
Oncologene 27(25)：3624-3634,2008.6.
36
Kitano S.,Tajiri H., Yasuda K., Ikdeda K., Sumiyama K., Nakajima K., Saida Y.
Current status and activity regarding Natural Orifice Translumenal Endoscopic Surgery (NOTES) in Japan
Asian J Endosc Surg 1 ,2008..
37
Kittaka N.,Takemasa I., Takeda Y., Marubashi S., Nagano H., Umeshita K., Dono K., Matsubara K., Matsuura N., Monden M.
Molecular mapping of human hepatocellular carcinoma provides deeper biological insight from genomic data
Eur J Cancer 44 885-897,2008..
38
Komori T.,Takemasa I., Yamasaki M., Motoori M., Kato T., Kikkawa N., Kawaguchi N., Ikeda M., Yamamoto H., Sekimoto M., Matsubara K., Matsuura N., Monden M.
Gene expression of colorectal cancer: Preoperative genetic diagnosis using endoscopic biopsies.
Int J Oncol. 32(2)：367-375,2008.2.
39
Kyo N.,Yamamoto H., Takeda Y., Ezumi K., Ngan CY., Terayama M., Miyake M., Takemasa I., Ikeda M., Doki Y., Dono K., Sekimoto M., Nojima H., Monden M.
Overexpression of connexin 26 in carcinoma of the pancreas.
Oncol Rep.? 19(3)：627-631,2008.3.
40
Lee C.,Fujii H., Komoda H., Matsuyama A., Kaneda Y., Sawa Y.?????
Molecular targeting of CD44 for Mesothelioma
Proceeeding of Inetrnational Congress of Neutron Capture Therapy 2008 13 347-349,2008..
41
Makino T.,Doki Y., Miyata H., Yasuda T., Yamasaki M., Fujiwara Y., Takiguchi S., Higuchi I., Hatazawa J., Monden M.
Use of 18F-fluorodeoxyglucose-positron emission tomography to evaluate responses to neo-adjuvant chemotherapy for primary tumor and lymph node metastasis in esophageal squamous cell carcinoma
Surgery 144(5)：793-802,2008..
42
Makino T.,Fujitani K., Tsujinaka T., Hirao M., Kashiwazaki M., Nakamori S., Ikenaga M., Mishima H., Masuda N., Sawamura T.
Role of percutaneous transhepatic biliary drainage in patients with obstructive jaundice caused by local recurrence of gastric cancer.
Hepatogastroenterology. 55(81)：54-57,2008.1.
43
Marubashi S.,Dono K., Miyamoto A., Takeda Y., Nagano H., Umeshita K., Monden M.
Impact of graft size on postoperative thrombocytopenia in living donor liver transplant.
Arch Surg. 142(11)：1054-1058,2007.11.
44
Matsumoto T.,Matsumoto T., Shibata K., Ohta M., Iwaki K., Uchida H., Yada K., Mori M., Kitano S.
Laparoscopic distal pancreatectomy and open distal pancreatectomy: a nonrandomized comparative study
Surg Laparosc Endosc Percutan Tech 18(4)：340-343,2008..
45
Matsuyama J.,Doki Y., Yasuda T., Miyata H., Fujiwara Y., Takiguchi S., Yamasaki M., Makari Y., Matsuura N., Mano M., Monden M.
The effect of neoadjuvant chemotherapy on lymph node micrometastases in squamous cell carcinomas of the thoracic esophagus.
Surgery 141(5)：570-580,2007..
46
Marubashi M.,Dono K., Nagano H., Kim C., Asaoka T., Hama N., Kobayashi S., Takeda Y., Umeshita K., Monden M., Doki Y., Mori M. Biliary reconstruction in living donor liver transplantation: technical invention and risk factor analysis for anastomotic strictureClin Transplan.2009
47
Mimori K.,Ishii H., Inoue H., Barnard GF., Mori M.
Identification of the expression profile of apoptotic esophageal cancer cells by adenoviral-fragile histidine triad treatment
Gastroenterology 23(2)：205-209,2008..
48
Mimori K.,Mimori K., Fukagawa T., Kosaka Y., Kita Y., Ishikawa K., Etoh T., Iinuma H., Sasako M., Mori M.
Hematogenous metastasis in gastric cancer requires isolated tumor cells and expression of vascular endothelial growth factor receptor-1
Clin Cancer Res 14(9)：2609-2616,2008.4.
49
Miyagaki H.,Fujitani K., Tsujinaka T., Hirao M., Yasui M., Kashiwazaki M., Ikenaga M., Miyazaki M., Mishima H., Nakamori S.
The significance of gastrectomy in advanced gastric cancer patients with non-curative factors
Anticancer Res 28(4)：2379-2384,2008..
50
Miyata H.,Doki Y., Yasuda T., Yamasaki M., Higuchi I., Makari Y., Matsuyama J., Hirao T.,? Takiguchi S., Fujiwara Y., Monden M.
Evaluation of clinical significance of 18F-fluorodeoxyglucose positron emission tomography in superficial squamous cell carcinomas of the thoracic esophagus
Diseases of the Esophagus
21 144-150,2008..
51
Miyoshi N.,Ohue M., Noura S., Yano M., Sasaki Y., Kishi K., Yamada T., Miyashiro I., Ohigashi H., Iishi H., Ishikawa O., Imaoka S.
Surgical usefulness of indocyanine green as an alternative to India ink for endoscopic marking
Surg Endosc,2008..
52
Miyoshi Y.,Kurosumi M., Kurebayashi J., Matsuura N., Takahashi M., Tokunaga E., Egawa C., Masuda N., Kim SJ., Okishiro M., Yanagisawa T., Ueda S., Taguchi T., Tamaki Y., Noguchi S.
Topoisomerase IIalpha-positive and BRCA1-negative phenotype: Association with favorable response to epirubicin-based regimens
for human breast cancers.
Cancer Lett 264(1)：44-53,2008..
53
Miyoshi Y.,Kurosumi M., Kurebayashi J., Matsuura N., Takahashi M., Tokunaga E., Egawa C., Masuda N., Kim SJ., Okishiro M., Yanagisawa T., Ueda S., Taguchi T., Tamaki Y., Noguchi S.
The Collaborative Study Group of Scientific Research of the Japanese Breast Cancer Society. Low nuclear grade but not cell proliferation predictive of pathological complete response to docetaxel in human breast cancers.
J Cancer Res Clin Oncol 134(5)：561-567,2008..
54
Monden M.
Changing Society, Evolving Surgery
Surgery Today 38 195-205,2008..
55
Motoyama K.,Inoue H., Nakamura Y., Uetake H., Sugihara K., Mori M.
Clinical significance of high mobility group A2 in human gastric cancer and its relationship to let-7 microRNA family
Clin Cancer Res 14(8)：2334-2340,2008.4.
56
Motoyama K.,Tanaka F., Kosaka Y., Mimori K., Uetake H., Inoue H., Sugihara K., Mori M.
Clinical significance of BMP7 in human colorectal cancer
Ann Surg Oncol 15(5)：1530-1537,2008.5.
57
Nakahira S.,NakamoriS., Tsujie M., Takeda S., Sugimoto K., Takahashi Y., Okami J., Marubashi S., Miyamoto A., Takeda Y., Nagano H., Dono K., Umeshita K., Sakon M.,? Monden M.
Pretreatment with S-1, an Oral Derivative of 5-Fluorouracil, Enhances Gemcitabine Effects in Pancreatic Cancer Xenografts.
ANTICANCER RESEARCH 28 179-186,2008..
58
Nakai N.,Ishikawa T., Nishitani A., Liu N., Shincho M., Hao H., Isozaki K., Kanda T., Nishida T., Fujimoto J., Hirota S.
A mouse model of human multiple GIST family with KIT-Asp820Tyr mutation generated by knock-in strategy
J Pathol 214(3)：302-311,2008..
59
Nakajima K.,Soh H., Nishida T.???
The Essentials in Pediatric Endoscopic Surgery (Saxena AK, Hollwarth ME eds; Springer Verlag, Heidelberg)
Laparoscopic liver wedge biopsy311-315,2008..
60
Nakajima K.,Takahashi T., Souma Y., Shinzaki S., Yamada T., Yoshio T., Nishida T.??
Transvaginal endoscopic partial gastrectomy in porcine models: the role of an extra endoscope for gastric control.
Surg Endosc 22(12)：2733-2736,2008..
61
Nakajima K.,Wasa M., Nishida T.???
Best Practices in Surgical Education: The Training of Registrars and Residents
Ethicon Endo-surgery, Inc,
62
Nakamura M.,Nagano H., Marubashi H., Miyamoto A., Takeda Y., Kobayashi S., Wada H.,
Noda T., Dono K ., Umeshita K., Monden M.
Pilot study of combination chemotherapy of S-1, a novel oral DPD inhibitor, and interferon-α for advanced hepatocellular carcinoma with extrahepatic metastasis
Cancer 112(8)：1766-1771,2008.4.
63
Nakamura Y.,Tanaka F., Yoshikawa Y., Mimori K., Inoue H., Yanaga K., Mori M.
PDGF-BB is a novel prognostic factor in colorectal cancer
Ann Surg Oncol 15(8)：2129-2136,2008..
64
Ngan CY.,Yamamoto H., Takagi A., Fujie Y., Takemasa I., Ikeda M., Yanaga F., Sasaguri T., Sekimoto M., Matsuura N., Monden M.
Oxaliplatin induces mitotic catastrophe and apoptosis in esophageal cancer cells.
Cancer Sci. 99(1)：129-139,2008..
65
Nishida T.,Hirota S., Yanagisawa A., Sugino Y., Minami M., Yamamura Y., Otani Y., Shimada Y., Takahashi F., Kubota T.
Clinical practice guideline for gastrointestinal stromal tumor (GIST) in Japan: English version
Inter J Clin Oncol.? 13 416-430,2008..
66
Nishida T.,Kanda T., Nishitani A., Takahashi T., Nakajima K., Ishikawa T., Hirota S.
Secondary mutations in the kinase domain of the KIT gene are predominant in imatinib-resistant gastrointestinal stromal tumor
Cancer Science 99(4)：799-804,2008..
67
Nishida T.,Shirao K., Sawaki A., Koseki M., Okamura T., Ohtsu A., Sugiyama T., Miyakawa K., Hirota S.
Efficacy and Safety Profile of Imatinib Mesylate (STI571) in Japanese Patients with Advanced Gastrointestinal Stromal Tumors: a Phase II Study
Inter J Clin Oncol.? 13 244-251,2008..
68
Nishikawa A.,Nakagoe H., Taniguchi K., Yamada Y., Sekimoto M., Takiguchi S., Monden M., Miyazaki F.
How does the camera assistant decide the zooming ratio of laparoscopic images? Analysis and implementation.
Med Image CCAIICMICCAI 11(2)：611-618,2008..
69
Nishikawa A.,Nakagoe H., Taniguchi K., Yamamoto Y., Sekimoto M., Monden M., Miyazaki F.
How Does the Camera Assistant Decide the Zooming Ratio of Laparoscopic Images? --Analysis and Implementation--. In Medical Image Computing and Computer-Assisted Intervention, Lecture Notes in Computer Science
Springer-Verlag 5242 611-618,2008..
70
Nishimura J.,Saiga H., Sato S., Okuyama M., Kayama H., Kuwata H., Matsumoto S., Nishida T., Sawa Y., Akira S., Yoshikai Y., Yamamoto M., Takeda K.
Potent antimycobacterial activity of mouse secretory leukocyte protease inhibitor
J Immunol. 180 4032-4039,2008..
71
Numasaki H.,Harauchi H., Ohno Y., Inamura? K., Kasahara S., Monden M., Sakon M.
New classification of medical staff clinical services for optimal reconstruction of job workflow in a surgical ward:Application of spectrum analysis and sequence relational analysis.
Computational Statistics & Data Analysis? 51(12)：5708-5717,2007..
72
Ohta M.,Mimori K., Fukuyoshi Y., Kita Y., Motoyama K., Yamashita K., Ishii H., Inoue H., Mori M.
Clinical significance of the reduced expression of G protein gamma 7 (GNG7) in esophageal cancer.
Br J Cancer 98 410-417,2008..
73
Okada K.,Yano M., Doki Y., Azama T., Iwanaga H., Miki H., Nakayama M., Miyata H., Takiguchi S., Fujiwara Y., Yasuda T., Ishida N., Monden M.
Injection of LPS causes transient suppression of biological clock genes in rats.
J Surg Res.? 145(1)：5-12,2008.3.
74
Omori T.,Nakajima K., Ohashi S., Takahashi T., Nishimura J., Sawa Y., Nishida T.??
Laparoscopic intragastric surgery under carbon dioxide pneumostomach.
J Laparoendosc Adv Surg Tech A. 18(1)：47-51,2008..
75
Pang R W.,Joh JW., Johnson PJ., Monden M., Pawlik TM., Poon RT.
Biology of hepatocellular carcinoma.
Ann Surg Oncol. 15(4)：962-971,2008.1.31
76
Park HL.,Kim MS, Yamashita K, Westra W, Carvalho AL, Lee J, Jiang WW, Baek JH, Liu J, Osada M, Moon CS, Califano JA, Mori M, Sidransky D.
DCC promoter hypermethylation in esophageal squamous cell carcinoma
Int J Cancer 122(11)：2498-2502,2008.1.
77
Saiga H.,Nishimura J., Kuwata H., Okuyama M., Matsumoto S., Sato S., Matsumoto M., Akira S., Yoshikai Y., Honda K., Yamamoto M., Takeda K.??
Lipocalin 2-Dependent Inhibition of Mycobacterial Growth in Alveolar Epithelium
J Immunol. 181 8521-8533,2008..
78
Sakashita K.,Mimori K., Tanaka F., Kamohara Y., Inoue H., Sawada T., Hirakawa K., Mori M.
Prognostic relevance of Tensin4 expression in human gastric cancer
Ann Surg Oncol 15(9)：2606-2613,2008..
79
Sakashita K.,Mimori K., Tanaka F., Kamohara Y., Inoue H., Sawada T., Hirakawa K., Mori M.
Clinical significance of loss of Fhl1 expression in human gastric cancer
Ann Surg Oncol 15(8)：2293-2300,2008..
80
Sakashita K.,Mimori K., Tanaka F., Kamohara Y., Inoue H., Sawada T., Hirakawa K., Mori M.
Prognostic relevance of Tensin4 expression in human gastric cancer
Ann Surg Oncol 15 58-58,2008.2.
81
Sakashita K.,Mimori K., Tanaka F., Tahara K., Inoue H., Sawada T., Ohira M., Hirakawa K., Mori M.
Clinical significance of low expression of prostasin mRNA in human gastric cancer
J Surg Oncol 98 559-564,2008..
82
Sakashita K.,Tanaka F., Xiang Z., Mimori K., Kamohara Y., Inoue H., Sawada T., Hirakawa K.,? Mori M.
Clinical significance of ApoE expression in human gastric cancer
Oncol Rep 20 1313-1319,2008..
83
Sasaki A.,Sasaki A., Tanaka F., Mimori K., Inoue H., Kai S., Shibata K., Ohta M., Kitano S., Mori M.
Prognostic value of tumor-infiltrating FOXP3+ regulatory T cells in patients with hepatocellular carcinoma
Eur J Surg Oncol 34 173-179,2008.4.
84
Serada S.,Fujimoto M., Mihara M., F Koike N., Ohsugi Y., Nomura S., Yoshida H., Nishikawa T., Terabe F., Ohkawara T., Takahashi T., Ripley B., Kishimoto T., Naka T.
IL-6 blockade inhibits the induction of myelin antigen specific Th17cells and Th1 cells in experimental autoimmune encephalomyelitis.
PNAS 105(26)：9041-9046,2008..
85
Serada S.,Fujimoto M., Mihara M., Koike N., Ohsugi Y., Nomura S., Yoshida H., Nishikawa F., Terabe F., Ohkawara T., Takahashi T., Ripley B., Kishimoto T., Naka T.?
IL-6 blockade inhibits the induction of myelin antigen specific Th17cells and Th1 cells in experimental autoimmune encephalomyelitis.
PNAS 105 9041-9046,2008..
86
Shimada K.,Ito T., Miao G., Tanemura M., Komoda H., Fumimoto Y., Kawamoto K., Nishida T., Kaneto H., Sawa Y.??
Regeneration of b-cells in the native pancreas after syngeneic and allogeneic pancreas transplantation in the spontaneously type 2 diabetic Torii rat.?
Transplant Proc. 40(2)：438-440,2008..
87
Shimada K.,Ito T., Tanemura M., Komoda H., Fumimoto Y., Kawamoto K., Nishida T., Kaneto H., Sawa Y.?????
Development of β-cells in the Native Pancreas after Pancreas Allo-transplantation in the Spontaneously Diabetic Torii Rat.
J Surg Res 145(2)：229-237,2008..
88
Shinzaki S.,Iijima H., Nakagawa T., Egawa S., Nakajima S., Ishii S., Irie T., Kakiuchi Y., Nishida T., Yasumaru M., Kanto T., Tsujii M., Tsuji S., Mizushima T., Yoshihara H., Kondo A.
IgG Oligosaccharide Alterations Are a Novel Diagnostic Marker for Disease Activity and the Clinical Course of Inflammatory Bowel Disease.
Am J Gastroenterol 103 1173-1181,2008..
89
Shiozaki M.,Yoshimura K., Shibata M., Koike M., Matsuura N., Uchiyama Y., Gotow T.
Morphological and biochemical signs of age-related neurodegenerative changes in klotho mutant mice.
Neuroscience 152(4)：924-941,2008..
90
Song J.,Matsuda C., Kai Y., Nishida T., Nakajima K., Mizushima T., Kinoshita M., Yasue T., Sawa Y., Ito T.
A novel sphingosine 1-phosphate receptor agonist, 2-amino-2-propanediol hydrochloride (KRP-203), regulates chronic colitis in interleukin-10 gene-deficient mice.
J Pharmacol Exp Ther 324 276-283,2008..
91
Takahashi T.,Naka T., Fujimoto M., Serada S., Horino J., Terabe F., Hirota S., Miyoshi E., Hirai T., Nakajima K., Nishitani A., Souma Y., Sawa Y., Nishida T.
Aberrant Expression of Glycosylation in Juvenile Gastrointestinal Stromal Tumors.
Proteomics. Clin. Appl. 2 1246-1254,2008..
92
Takahashi T.,Naka T., Fujimoto M., Serada S., Horino J., Terabe F., Hirota S., Miyoshi E., Hirai T., Nakajima K., Nishitani A., Souma Y., Sawa Y., Nishida T.?
Rikkunshito, a Chinese herbal medicine, improves stasis of patients with pylorus-preserving gastrectomy.
World J Surg. 2 1246-1254,2008..
93
Takeno A.,Takemasa I., Doki Y., Yamasaki M., Miyata H., Takiguchi S., Fujiwara Y., Matsubara K., Monden M.
Integrative approach for differentially overexpressed genes in gastric cancer by combining large-scale gene expression profiling and network analysis.
Br J Cancer 21(99)：1307-1315,2008.10.
94
Tanaka F .,Haraguchi N., Ishikawa K., Inoue H., Mori M.
Potential role of dendritic cell vaccination with MAGE peptides in gastrointestinal carcinomas
Oncol Rep 20 1111-1116,2008..
95
Tanemura M.,Saga A., Kawamoto K., Deguchi T., Machida T., Nishida T., Sawa Y., Ito T.
In vitro and in vivo prevention of human CD8+ CTL-mediated xenocytotoxicity by pig c-FLIP expression in porcine endothelial cells.
Am J Transplant. 8(2)：288-297,2008..
96
Tanemura M.,Saga A., Kawamoto K., Deguchi T., Machida T., Nishida T., Sawa Y., Ito T.
Pig cellular FLICE-like inhibitory protein (c-FLIP) overexpression in pig xenograft cells induces resistance to human CD8+ cytotoxic T lymphocyte-mediated xenocytotoxicity.
Transplant Proc.? 40(2)：559-563,2008..
97
Taniguchi K,Nishikawa A., Kobayashi T., Kazuhara K., Ichihara T., Kurashita N., Sekimoto M.,
Takiguchi S., Monden M., Miyazaki F.
A Disposable Laparoscope Manipulator using Hydraulic Actuators with Air Spring.
International Journal of Computer Assisted Radiology and Surgery 3(1)：122-,2008..
98
Taniguchi K,Nishikawa A., Kobayashi T., Kazuhara K., Ichihara T., Kurashita N., Sekimoto M.,
Takiguchi S., Monden M., Miyazaki F.
A Disposable Laparoscope Manipulator using Hydraulic Actuators
In Proceedings of 2008 Emerging Technology Session of the Society of American Gastrointestinal and Endoscopic Surgeons318-319,2008..
99
Taniguchi K.,Nishikawa A., Kobayashi T., Kazuhara K., Ichihara T., Kurashita N., Sekimoto M.,
Takiguchi S., Monden M., Miyazaki F.
Development of a Disposable Laparoscope Manipulator using Hydraulic Actuators (Second Prototype)
Minimally Invasive Therapy and Allied Technologies 17(4)：211-212,2008..
100
Tian H.,Miyoshi E., Kawaguchi N., Shaker M., Ito Y., Taniguchi N., Tsujimoto M., Matsuura N.
The implication of N-acetylglucosaminyltransferase V expression in gastric cancer.
Pathobiology? 75(5)：288-294,2008..
101
Tokumaru Y.,Yamashita K., Kim MS., Park HL., Osada M., Mori M., Sidransky D.
The role of PGP9.5 as a tumor suppressor gene in human cancer
Int J Cancer 123(4)：753-759,2008.8.
102
Tomimaru Y.,Noura S., Ohue M., Okami J., Oda K., Higashiyama M., Yamada T., Miyashiro I., Ohigashi H., Yano M., Kodama K., Ishikawa O., Murata K., Yokouchi H.,
Sasaki Y., Kameyama M., Imaoka S.
Metastatic tumor doubling time is an independent predictor of intrapulmonary recurrence after pulmonary resection of solitary pulmonary metastasis from colorectal cancer.
Dig Surg 25(3)：220-225,2008..
103
Tomimaru Y.,Takeda Y., Kobayashi S., Marubashi S., Lee CM., Tanemura M., Nagano H., Kitagawa T., Dono K., Umeshita K., Monden M.
Comparison of postoperative morphological changes in remnant pancreas between pancreaticojejunostomy and pancreaticogastrostomy after pancreaticoduodenectomy.
Pancreas,2008..
104
Tomimaru Y.,Yano M., Takachi K., Kishi K., Miyashiro I., Ohue M., Ohigashi H., Sasaki Y., Ishikawa O., Imaoka S.
Correlation between pretherapeutic D-dimer levels and response to neoadjuvant chemotherapy in patients with advanced esophageal cancer.
Dis Esophagus 21(4)：281-287,2008..
105
Torikai K.,Ichikawa H., Hirakawa K., Matsumiya G., Kuratani T., Iwai S., Saito A., Kawaguchi N., Matsuura N., Sawa Y.
A self-renewing, tissue-engineered vascular graft for arterial reconstruction.
J Thorac Cardiovasc Surg? 136(1)：37-45,2008..
106
Ueda K.,Nakanishi T., Shimizu A., Takubo T., Matsuura N.
Identification of L-plastin autoantibody in plasma of patients with non-Hodgkin's lymphoma using a proteomics-based analysis.
Ann Clin Biochem 45(1)：65-69,2008..
107
Wada H.,Sato E., Uenaka A., Isobe M., Kawabata R., Nakamura Y., Iwae S.,? Yonezawa K., Yamasaki M., Miyata H., Doki Y., Shiku H., Achim A. Jungbluth, Gerd Ritter, Roger Murphy, Eric W. Hoffman, Lloyd J. Old, Monden M., Nakayama E.
Analysis of peripheral and local anti-tumor immune response in esophageal cancer patients after NY-ESO-1 protein vaccination
Int. J. Cancer 123 2362-2369,2008..
108
Watanabe M.,Takemasa I., Kawaguchi N., Miyake M., Nishimura N., Matsubara T., Matsuo E., Sekimoto M., Nagai K., Matsuura N., Monden M., Nishimura O.
An application of the 2-nitrobenzenesulfenyl method to proteomic profiling of human colorectal carcinoma: A novel approach for biomarker discovery.
Proteomics Clin Appl. 2 925-935,2008..
109
Xu X.,Yamamoto H., Liu G., Ito Y., Ngan CY., Kondo M., Nagano H., Dono K., Sekimoto M., Monden M.
CDC25A inhibition suppresses the growth and invasion of human hepatocellular carcinoma cells.
Int J Mol Med.? 21(2)：145-152,2008..
110
Yamamoto H.,Ngan CY., Monden M.
Cancer cells survive with survivin.
Cancer Sci. 99(9)：1709-1714,2008..
111
Yamamoto H.,Noura S., Okami J., Uemura M., Takemasa I., Ikeda M., Ishii H., Sekimoto M., Matsuura N., Monden M., Mori M.
Overexpression of MT1-MMP is insufficient to increase experimental liver metastasis of human colon cancer cells.
Int J Mol Med. 22(6)：757-761,2008..
112
Yamamura N.,Nakajima K., Takahashi T., Uemura M., Nishitani A., Souma Y., Nishida T.
Intra-abdominal textiloma: a case of retained surgical sponge mimicking a gastric SMT
Surg Today 38 552-554,2008..
113
Yamamura N.,Nakajima K., Takahashi T., Uemura M., Nishitani A., Souma Y., Nishida T.
Intra-abdominal textiloma. A retained surgical sponge mimicking a gastric gastrointestinal stromal tumor: report of a case
Surgery Today 38(6)：552-554,2008..
114
Yamashita K.,Kim MS., Park HL., Tokumaru Y., Osada M., Inoue H., Mori M., Sidransky D.
HOP/OB1/NECC1 promoter DNA is frequently hypermethylated and involved in tumorigenic ability in esophageal squamous cell carcinoma
Mol Cancer Res 6(1)：31-41,2008.1.
115
Yokoe T.,Yokoe T., Tanaka F., Miori K., Inoue H., Ohmachi T., Kusunoki M., Mori M.
Efficient identification of a novel cancer testis antigen as a candidate of cancer immunotherapy using three-step microarray analysis
Cancer Res 68(4)：1074-1082,2008.4.
116
Yokota T.,Ichikawa H., Matsumiya G., Kuratani T., Sakaguchi T., Iwai S., Shirakawa Y., Torikai K., Saito A., Uchimura E., Kawaguchi N., Matsuura N., Sawa Y.
In situ tissue regeneration using a novel tissue-engineered, small-caliber vascular graft without cell seeding.
J Thorac Cardiovasc Surg 136(4)：900-907,2008..
117
Yoshinaga K.,Mimori K., Inoue H., Kamohara Y., Yamasshita K., Tanaka F., Mori M.
Activin A enhances MMP-7 activin via the transcription factor AP-1 in an esophageal squamous cell carcinoma cell line
Int J Oncol 33 453-459,2008..
118
Yoshinaga K.,Yoshinaga K., Yamashita K., Mimori K., Tanaka F., Inoue H., Mori M.
Activin a causes cancer cell aggressiveness in esophageal squamous cell carcinoma cells
Ann Surg Oncol 15(1)：96-103,2008.4.
119
Yoshioka A.,Miyata H., Doki Y., Yamasaki M., Sohma I., Gotoh K., Takiguchi S., Fujiwara Y., Uchiyama Y., Monden M.
LC3, an autophagosome marker, is highly expressed in gastrointestinal cancers.
Int J Oncol 33 461-468,2008..
120
Yoshioka A.,Miyata H., Doki Y., Yasuda T.,Yamasaki M., Motoori M., Okada K., Matsuyama J., Makari Y., Sohma I., Takiguchi S., Fujiwara Y., Monden M.
The activation of Akt during preoperative chemotherapy for esophageal cancer correlates with poor prognosis
Oncol Rep 19 1099-1107,2008..
121
Zhang X.,Zhang X., Nagahara H., Mimori K., Inoue H., Sawada T., Ohira M., Hirakawa K., Mori M.
Mutations of epidermal growth factor receptor in colon cancer indicate susceptibility or resistance to gefitinib.
Oncology Rep 19 1541-1544,2008.4.
122
Zhang Y.,Fujiwara Y., Doki Y., Takiguchi S., Yasuda T., Miyata H., Yamazaki M.,
Ngan CY., Yamamoto H., Ma Q., Monden M.
Overexpression of tyrosine kinase B protein as a predictor for distant metastases and prognosis in gastric carcinoma.
Oncology 75(1-2)：17-26,2008..